Detalhe da pesquisa
1.
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 777-789, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351722
2.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 790-802, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351721
3.
A comparison of computational algorithms for the Bayesian analysis of clinical trials.
Clin Trials
; : 17407745241247334, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38752434
4.
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers : A Randomized Trial.
Ann Intern Med
; 175(12): 1629-1638, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442064
5.
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
JAMA
; 329(13): 1066-1077, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36942550
6.
Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis.
Crit Care Med
; 50(4): e370-e381, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636806
7.
Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding.
Crit Care Med
; 48(4): 515-524, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32205598
8.
Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
N Engl J Med
; 385(9): 857-859, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233107
9.
Outcomes of hospitalized hematologic oncology patients receiving rapid response system activation for acute deterioration.
Crit Care
; 23(1): 286, 2019 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455376
10.
Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis.
JAMA
; 312(11): 1122-35, 2014 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25226478
11.
Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day.
J Thromb Haemost
; 22(1): 255-262, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37838241
12.
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey.
J Thromb Haemost
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582384
13.
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.
Nat Rev Cardiol
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509244
14.
DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature.
J Thromb Haemost
; 21(3): 433-452, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696204
15.
Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.
J Thromb Haemost
; 21(6): 1666-1673, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921919
16.
Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale.
TH Open
; 7(3): e229-e240, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497426
17.
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation.
J Thromb Haemost
; 21(5): 1381-1384, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796485
18.
Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature.
PLoS One
; 18(11): e0293632, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37910528
19.
Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial.
Res Pract Thromb Haemost
; 7(7): 102203, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854455
20.
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.
Res Pract Thromb Haemost
; 7(6): 102167, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37727846